One moment please...


We hope the following resources help you gain a deeper understanding of neuromodulation, rTMS (repetitive transcranial magnetic stimulation) treatments, and the neuroCare clinics.

Sleep and Mental Health

The following infographic presents facts and figures collated from a number of surveys and papers.

Sleep disorders have been linked to ADHD, depression, and OCD.

Modern lifestyle factors such as the influence of blue light can negatively affect our circadian rhythms.

The path to good mental health starts with good “sleep hygiene”.

Getting the right amount of quality sleep leads to a range of health benefits.


Click on the videos below to see interviews with Dr Martijn Arns, neuromodulation expert and Global Chief Scientific Advisor for the neuroCare Group.

Watch more videos here

Clinical Indications for rTMS

Dr Arns explains which patients may expect to see results from rTMS (repetitive transcranial magnetic stimulation) treatments, and why rTMS is not currently used for treatment in adolescents, pregnant women, and patients diagnosed with anxiety or psychotic depression.

The Potential Side Effects of rTMS

Dr Arns explains the various contraindications and likelihood of side effects resulting from rTMS treatment.

Typical Response & Remission Rates of rTMS

Dr Arns explains the encouraging efficacy rates of rTMS therapy as indicated by large open-label studies. Further to this, Dr Arns explains why he suspects there may be an enhanced clinical response when rTMS is co-administered with eclectic, personalised psychotherapy when compared to rTMS administration as a monotherapy.

Key Differences Between rTMS and Electroconvulsive Therapy

Dr Arns makes the case for rTMS being considered as the stage before ECT (electroconvulsive therapy) citing the lower side effect rate of rTMS therapy when compared to either ECT or the prescription of SSRIs (selective serotonin reuptake inhibitors).

Key Differences Between High Frequency & Low Frequency rTMS Protocols

Dr Arns talks about the exciting research being conducted with regards to high and low frequency protocols and the new treatment methods which have been recently approved by the American FDA (Food and Drug Administration).

The Principle for Choosing the Dorsolateral Prefrontal Cortex for rTMS

Dr Arns looks into the current state of research and the rationale for preferencing dorsolateral prefrontal cortex stimulation over stimulation of other areas of the brain.

Localising the Exact Point for Maximum Stimulation for rTMS

Dr Arns discusses the current theories behind methods of locating the point of stimulation, and looks at some of the experimental methods used in the United States considering functional connectivity based on MRI (magnetic resonance imaging).

Scientific Publications

Click on the Scientific Publications link to visit the neuroCare Group website, and read about the scientific research that provides the base for the neuroCare Clinics and their use of neuromodulation and rTMS therapy.

Are you considering the Auditory Training Program for you or your child?

We offer the Auditory Training Program in Sydney and Melbourne

Are you a therapist looking to be trained in this technique?

Martha Mack, Australia’s most experienced ATP provider, is offering workshops in 2018.

Logo neuroCare bunt Poster vector white 1

Personalising Mental Healthcare since 2001, using state-of-the-art neuromodulation to help children, adults and their families achieve lasting mental wellness.

To learn more about what we do worldwide

neuroCademy Professional Training & Science


neuroCare Sydney
Level 19, 56 Pitt St
Sydney NSW 2000

T: (02) 8317 5032
Fax:  (02) 8038 6334
E: [email protected]


neuroCare Frenchs Forest
Suite 4, Building 7
49 Frenchs Forest Rd East
Frenchs Forest NSW 2086

T: (02) 9453 5735
Fax: (02) 9452 6815
E: [email protected]



neuroCare East Melbourne
Level 8, 372 Albert St
East Melbourne VIC 3002

T: (03) 9816 8811
Fax:  (03) 9817 5399
E: [email protected]


neuroCare Balwyn
Level 1, 66 Whitehorse Rd
Balwyn VIC 3103

T: (03) 9816 8811
Fax:  (03) 9817 5399
E: [email protected]

Copyright neuroCare Group Pty Ltd. 2020. All rights reserved.

Digital Marketing by Supple
Call Now ButtonCall now